Stay updated on Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page.

Latest updates to the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page
- CheckyesterdayChange DetectedA notice was added about NIH website changes and the transition to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) across federal agency content.SummaryDifference0.3%

- Check8 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1; the study record content remains unchanged.SummaryDifference0.0%

- Check15 days agoChange DetectedThe website footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check29 days agoChange DetectedThe page now displays Revision: v3.7.0 instead of v3.6.6. This reflects a software release/version update for the site.SummaryDifference0.0%

- Check57 days agoChange DetectedThe history page now shows a new site revision (v3.6.6) replacing the previous revision (v3.6.5). This represents a minor, behind-the-scenes update to the page's interface/back-end.SummaryDifference0.0%

- Check78 days agoChange DetectedThe record history shows a new revision, v3.6.5, replacing the previous v3.6.4, indicating a minor version update to the page's metadata. This does not alter the study data or substantive content of the record.SummaryDifference0.0%

Stay in the know with updates to Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page.